{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:49:33Z","timestamp":1772520573114,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.08.035","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T10:52:57Z","timestamp":1221043977000},"page":"5802-5807","source":"Crossref","is-referenced-by-count":10,"title":["Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus"],"prefix":"10.1016","volume":"26","author":[{"given":"Peng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Sheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Xiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.08.035_bib1","series-title":"The togaviruses","first-page":"47","article-title":"Medical significance of togaviruses: an overview of diseases caused by togaviruses in man and in domestic and wild vertebrate animals","author":"Shope","year":"1980"},{"key":"10.1016\/j.vaccine.2008.08.035_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4269\/ajtmh.1999.61.677","article-title":"Complete nucleotide sequence of an Indian strain of Japanese encephalitis virus: sequence comparison with other strains and phylogenetic analysis","volume":"61","author":"Vrati","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.08.035_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome rganization, expression and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib4","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","article-title":"Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein","volume":"70","author":"Mason","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib5","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1128\/JVI.73.12.10137-10145.1999","article-title":"Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines","volume":"73","author":"Chen","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-1702(01)00246-5","article-title":"Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein","volume":"76","author":"Wu","year":"2001","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2008.08.035_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/viro.1999.9859","article-title":"Prediction of three-dimensional structure and mapping of conformational epitopes","volume":"261","author":"Kolaska","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.035_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0264-410X(95)00097-K","article-title":"Finger mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichiacoli system","volume":"13","author":"Seif","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.035_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s007050050043","article-title":"Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes","volume":"145","author":"Takada","year":"2000","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0161-5890(91)90098-5","article-title":"Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis. West Nile and Dengue viruses","volume":"28","author":"Kutubuddin","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib11","series-title":"Vaccines","first-page":"672","article-title":"Japanese encephalitis vaccines","author":"Tsai","year":"1999"},{"key":"10.1016\/j.vaccine.2008.08.035_bib12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0140-6736(91)92707-9","article-title":"Side-effects with Japanese encephalitis vaccine","volume":"337","author":"Andersen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.08.035_bib13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(97)00020-0","article-title":"Allergic mucocutaneous reactions to Japanese encehalitis vaccine","volume":"15","author":"Plesner","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.035_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-409X(01)00164-8","article-title":"Nasal delivery of epitope-based vaccines","volume":"51","author":"Olszewska","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2008.08.035_bib15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1006\/viro.1993.1203","article-title":"Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc","volume":"193","author":"Both","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.035_bib16","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1128\/JVI.77.13.7663-7668.2003","article-title":"Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"Casimiro","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0264-410X(95)00032-V","article-title":"Adenovirus vectors as recombinant viral vaccines","volume":"13","author":"ImLer","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.035_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.08.035_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/viro.2001.1281","article-title":"Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses","volume":"293","author":"Sharpe","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.035_bib20","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/S0264-410X(03)00266-4","article-title":"Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv\/rev and Ad5hr-SIVgag recombinants","volume":"21","author":"Zhao","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.035_bib21","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib22","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.86.17.6763","article-title":"Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus","volume":"86","author":"Lubeck","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.08.035_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.vetimm.2006.05.012","article-title":"Fusion expression of major antigenic segment of JEV E protein-hsp70 and the identification of domain acting as adjuvant in hsp70","volume":"113","author":"Ge","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib24","first-page":"189","article-title":"Passive immune serum inhibits antibody response to recombinant vacinia virus","volume":"vol. 88","author":"Johnson","year":"1988"},{"key":"10.1016\/j.vaccine.2008.08.035_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13550280390218454","article-title":"Development of a recombinant vaccine against Japanese encephalitis","volume":"9","author":"Kaur","year":"2003","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib26","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1128\/JVI.77.23.12907-12913.2003","article-title":"Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2","volume":"77","author":"Jaiswal","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0264-410X(94)90206-2","article-title":"Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice","volume":"12","author":"Fonseca","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.035_bib28","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib29","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/JVI.68.5.3283-3288.1994","article-title":"Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8\u2212 cytotoxic T-cell clones","volume":"68","author":"Livingston","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4269\/ajtmh.1993.48.412","article-title":"Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein","volume":"48","author":"Jan","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.08.035_bib31","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib32","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1128\/JVI.75.23.11457-11463.2001","article-title":"Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses","volume":"75","author":"Pan","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib33","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1099\/0022-1317-82-9-2191","article-title":"Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration","volume":"82","author":"Vos","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-1119(96)00620-8","article-title":"Recombinant adenovirus synthesizing cell surface-anchored beta hCG induces bioneutralizing antibodies in rats","volume":"190","author":"Raikwar","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2008.08.035_bib35","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immune-oglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib36","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","article-title":"Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.035_bib37","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1073\/pnas.0400339101","article-title":"Interleukin 2 plays a central role in Th2 differentiation","volume":"101","author":"Cote-Sierra","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.08.035_bib38","first-page":"925","article-title":"The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation","volume":"16","author":"Jelinek","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.144.2.562","article-title":"IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2)","volume":"144","author":"Splawski","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2004.00203.x","article-title":"Cytokine and immunodeficiency diseases: critical roles of the gamma (c)-dependent cytokines interleukins 2, 4, 7, 9, 15 and 21, and their signaling pathways","volume":"202","author":"Kovanen","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2008.08.035_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/104303403764539323","article-title":"Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector","volume":"14","author":"Varnavski","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2008.08.035_bib42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P","article-title":"Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells","volume":"29","author":"Zhong","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1086\/381768","article-title":"Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae","volume":"189","author":"Kumar","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.08.035_bib44","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00705-003-0118-5","article-title":"Screening for T cell eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations","volume":"148","author":"Kumar","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2008.08.035_bib45","doi-asserted-by":"crossref","first-page":"C169","DOI":"10.1016\/j.vetimm.2006.05.001","article-title":"Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice","volume":"113","author":"Jiang","year":"2006","journal-title":"Vet. Immunol. Immunopathol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T22:18:34Z","timestamp":1684534714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":45,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08011407"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}